# Liposomal vs. Conventional Bupivacaine for Pain Control

> **NCT06231355** · PHASE4 · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 61 (actual)

## Conditions studied

- Local Anesthetics
- Analgesia
- Regional Block
- Paravertebral Block

## Interventions

- **DRUG:** Performing paravertebral nerve block with lipo-bupivacaine
- **DRUG:** Performing paravertebral nerve block with bupivacaine

## Key facts

- **NCT ID:** NCT06231355
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-21
- **Primary completion:** 2024-09-09
- **Final completion:** 2024-10-14
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06231355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06231355, "Liposomal vs. Conventional Bupivacaine for Pain Control". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06231355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*